Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancerRavi A. Madan, James L. Gulley, Renee N. Donahue et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 31